Groupama Asset Managment Ionis Pharmaceuticals Inc Transaction History
Groupama Asset Managment
- $6.04 Trillion
- Q2 2025
A detailed history of Groupama Asset Managment transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Groupama Asset Managment holds 1,160,957 shares of IONS stock, worth $47.8 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
1,160,957
Previous 1,069,211
8.58%
Holding current value
$47.8 Million
Previous $18.2 Billion
47.23%
% of portfolio
0.44%
Previous 0.36%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
406Shares Held
148MCall Options Held
872KPut Options Held
432K-
Vanguard Group Inc Valley Forge, PA16.7MShares$688 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$666 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$516 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$347 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...